Morpholine → HCID 68663245, compound

HRID 452791Notes

Reaction equation

[F:1][C:2]1[CH:10]=[C:9]([C:11]2[C:15]3[CH:16]=[C:17]([C:20]4[O:21][C:22]([CH3:25])=[N:23][N:24]=4)[CH:18]=[CH:19][C:14]=3[O:13][CH:12]=2)[CH:8]=[CH:7][C:3]=1[C:4]([OH:6])=O.[NH:26]1[CH2:31][CH2:30][O:29][CH2:28][CH2:27]1>>[F:1][C:2]1[CH:10]=[C:9]([C:11]2[C:15]3[CH:16]=[C:17]([C:20]4[O:21][C:22]([CH3:25])=[N:23][N:24]=4)[CH:18]=[CH:19][C:14]=3[O:13][CH:12]=2)[CH:8]=[CH:7][C:3]=1[C:4]([N:26]1[CH2:31][CH2:30][O:29][CH2:28][CH2:27]1)=[O:6]

Participants

Reactant 2

HCID 8083Morpholine

HCID 68664688HCID 68664688, compound

Product 1

HCID 68663245HCID 68663245, compoundYield 78%

Procedure

In the same manner as in Example 117 and using 2-fluoro-4-[5-(5-methyl-1,3,4-oxadiazol-2-yl)-1-benzofuran-3-yl]benzoic acid instead of 3-[5-(2,3-dihydro-1-benzofuran-5-yl)-1,3,4-oxadiazol-2-yl]propionic acid and using morpholine instead of N,O-dimethylhydroxyamine hydrochloride, the title compound (yield 78%) was obtained as colorless crystals.

Sources & evidence

ORD record: ord-bf8346e19f2e41f88270ddddffda013e
Source dataset: uspto-grants-2013_07
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US08492378B2

Reaction notes

Loading…